<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Knitza J</submitter><funding>Universitätsklinikum Erlangen</funding><funding>Thermo Fisher Scientific, Freiburg, Germany</funding><funding>Deutsche Forschungsgemeinschaft</funding><pagination>125</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9130452</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>24(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Rheumatoid arthritis (RA) requires early diagnosis and tight surveillance of disease activity. Remote self-collection of blood for the analysis of inflammation markers and autoantibodies could improve the monitoring of RA and facilitate the identification of individuals at-risk for RA.&lt;h4>Objective&lt;/h4>Randomized, controlled trial to evaluate the accuracy, feasibility, and acceptability of an upper arm self-sampling device (UA) and finger prick-test (FP) to measure capillary blood from RA patients for C-reactive protein (CRP) levels and the presence of IgM rheumatoid factor (RF IgM) and anti-cyclic citrullinated protein antibodies (anti-CCP IgG).&lt;h4>Methods&lt;/h4>RA patients were randomly assigned in a 1:1 ratio to self-collection of capillary blood via UA or FP. Venous bl</pubmed_abstract><journal>Arthritis research &amp; therapy</journal><pubmed_title>Accuracy and tolerability of self-sampling of capillary blood for analysis of inflammation and autoantibodies in rheumatoid arthritis patients-results from a randomized controlled trial.</pubmed_title><pmcid>PMC9130452</pmcid><funding_grant_id>2886</funding_grant_id><pubmed_authors>Aubourg T</pubmed_authors><pubmed_authors>Matusewicz P</pubmed_authors><pubmed_authors>Kleyer A</pubmed_authors><pubmed_authors>Bendzuck G</pubmed_authors><pubmed_authors>Boeltz S</pubmed_authors><pubmed_authors>Hueber AJ</pubmed_authors><pubmed_authors>Kronke G</pubmed_authors><pubmed_authors>Knitza J</pubmed_authors><pubmed_authors>Eimer E</pubmed_authors><pubmed_authors>Korinth M</pubmed_authors><pubmed_authors>Vuillerme N</pubmed_authors><pubmed_authors>Corte G</pubmed_authors><pubmed_authors>Elling-Audersch C</pubmed_authors><pubmed_authors>Schett G</pubmed_authors><pubmed_authors>Simon D</pubmed_authors><pubmed_authors>Schuster L</pubmed_authors><pubmed_authors>Tascilar K</pubmed_authors></additional><is_claimable>false</is_claimable><name>Accuracy and tolerability of self-sampling of capillary blood for analysis of inflammation and autoantibodies in rheumatoid arthritis patients-results from a randomized controlled trial.</name><description>&lt;h4>Background&lt;/h4>Rheumatoid arthritis (RA) requires early diagnosis and tight surveillance of disease activity. Remote self-collection of blood for the analysis of inflammation markers and autoantibodies could improve the monitoring of RA and facilitate the identification of individuals at-risk for RA.&lt;h4>Objective&lt;/h4>Randomized, controlled trial to evaluate the accuracy, feasibility, and acceptability of an upper arm self-sampling device (UA) and finger prick-test (FP) to measure capillary blood from RA patients for C-reactive protein (CRP) levels and the presence of IgM rheumatoid factor (RF IgM) and anti-cyclic citrullinated protein antibodies (anti-CCP IgG).&lt;h4>Methods&lt;/h4>RA patients were randomly assigned in a 1:1 ratio to self-collection of capillary blood via UA or FP. Venous bl</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 May</publication><modification>2026-06-04T07:59:09.449Z</modification><creation>2024-11-11T23:02:04.85Z</creation></dates><accession>S-EPMC9130452</accession><cross_references><pubmed>35614488</pubmed><doi>10.1186/s13075-022-02809-7</doi></cross_references></HashMap>